Pharmacotherapeutic potential of malvidin to cure imidacloprid induced hepatotoxicity via regulating PI3K/AKT, Nrf-2/Keap-1 and NF-κB pathway
Food and Chemical Toxicology · 2024
DOI: 10.1016/j.fct.2024.114816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2024. Verfasst von Henry Edwards und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, The University of Melbourne, Australia. Electronic address: henryedwards.unimelb@gmail.com. Hauptthemen laut MEDLINE: Anthocyanins, Chemical and Drug Induced Liver Injury, Imidazoles, Liver. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: King Saud University.
Abstract (Originalsprache)
Imidacloprid (IMI) is one of the top-notch insecticides that adversely affects the body organs including the liver. Malvidin (MAL) is a natural flavonoid which exhibits a wide range of pharmacological properties. This research was designed to evaluate the protective ability of MAL to counteract IMI instigated liver toxicity in rats. Thirty-two rats were divided into four groups including control, IMI (5mg/kg), IMI (5mg/kg) + MAL (10mg/kg) and MAL (10mg/kg) alone treated group. The recommended dosages were administrated through oral gavage for 4 weeks. It was revealed that IMI intoxication disrupted the PI3K/AKT and Nrf-2/Keap-1 pathway. Furthermore, the activities of catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), heme-oxygenase-1 (OH-1) and glutathione reductase (GSR) were reduced while upregulating reactive oxygen species (ROS) and malondialdehyde (MDA) levels after IMI treatment. Moreover, IMI poisoning increased the levels of ALT (Alanine aminotransferase), AST (Aspartate transaminase), and ALP (Alkaline phosphatase) while reducing the levels of total proteins and albumin in hepatic tissues of rats. Besides, IMI administration escalated the expressions of Bcl-2-associated protein x (Bax) and cysteine-aspartic acid protease-3 (Caspase-3) while downregulating the expressions of B-cell lymphoma 2 (Bcl-2). Similarly, IMI intoxication, increased the levels of Interleukin-6 (IL-6), Nuclear factor kappa-B (NF-κB), Interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and the activity of cyclooxygenase-2 (COX-2). Furthermore, IMI disrupted the normal architecture of hepatic tissues. However, MAL treatment remarkably protected the liver tissues via regulating abovementioned disruptions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, The University of Melbourne, Australia. Electronic address: henryedwards.unimelb@gmail.com.
- Department of Zoology, Wildlife and Fisheries, University of Agriculture, Faisalabad, Pakistan.
- Department of Food Science & Nutrition, College of Food and Agricultural Sciences, King Saud University, 11 P.O. Box 2460, Riyadh, 11451, Saudi Arabia.
- Department of Chemistry and Biochemistry, Faculty of Medicine and Pharmacy, Ibn Zohr University, Laayoune, 70000, Morocco.
- Department of Zoology, Government College University, Faisalabad, Pakistan.
Förderung
- King Saud University
Zitieren
APA
Edwards, H., Mustfa, W., Tehreem, S., Salamatullah, A. M., Bourhia, M., & Ghafoor, A. (2024). Pharmacotherapeutic potential of malvidin to cure imidacloprid induced hepatotoxicity via regulating PI3K/AKT, Nrf-2/Keap-1 and NF-κB pathway. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2024.114816
Vancouver
Edwards H, Mustfa W, Tehreem S, Salamatullah AM, Bourhia M, Ghafoor A. Pharmacotherapeutic potential of malvidin to cure imidacloprid induced hepatotoxicity via regulating PI3K/AKT, Nrf-2/Keap-1 and NF-κB pathway. Food and Chemical Toxicology. 2024. doi:10.1016/j.fct.2024.114816
BibTeX
@article{Edwards2024,
author = {Edwards, Henry and Mustfa, Warda and Tehreem, Shahaba and Salamatullah, Ahmad Mohammad and Bourhia, Mohammed and Ghafoor, Ayesha},
title = {Pharmacotherapeutic potential of malvidin to cure imidacloprid induced hepatotoxicity via regulating PI3K/AKT, Nrf-2/Keap-1 and NF-κB pathway},
journal = {Food and Chemical Toxicology},
year = {2024},
doi = {10.1016/j.fct.2024.114816}
}
EUVIMED